1 / 4

Nuclear Medicine/Radiopharmaceuticals Market 2020 Analysis and Advancement Outlook

Global Nuclear Medicine/Radiopharmaceuticals Market was valued at USD 6.5 billion in 2019 which is expected to reach USD 12.25 billion by 2027 at a CAGR 9.88%.

Markettrend
Download Presentation

Nuclear Medicine/Radiopharmaceuticals Market 2020 Analysis and Advancement Outlook

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nuclear Medicine/Radiopharmaceuticals Market-Size, Business Analysis and Growth Rate Report In the report,Nuclear Medicine/Radiopharmaceuticals Market thas been analyzed through a segmental perspective. The market segmentation allows a deeper understanding of the market hotspots. Global Nuclear Medicine/Radiopharmaceuticals Market was valued at USD 6.5 billion in 2019 which is expected to reach USD 12.25 billion by 2027 at a CAGR 9.88%. Nuclear medicines/radiopharmaceuticals are radioactive compounds which are administered to patients and monitored via special imaging devices. These are used to diagnosis and therapeutic purposes. Nuclear medicines or radiopharmaceutical components are composed of organic molecules with radioisotopes. Radioisotopes emits gamma rays are used for diagnosis.Increase in incidences of chronic diseases like cancer is the key driving factor which is expected to boost the global nuclear medicine/ radiopharmaceuticals market growth. For instance, in 2018, according to World Health Organization (WHO) around 9.6 million people were dead due to cancer across the world. Get Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Nuclear- MedicineRadiopharmaceuticals-Market/request-sample

  2. Also, increase in prevalence of cardiovascular diseases will have the positive impact on global nuclear medicine/ radiopharmaceuticals market growth. Furthermore, increase in technological advancements is expected to propel the global nuclear medicine/ radiopharmaceuticals market growth. However, short life of radiopharmaceuticals is the restraining factor for market which is expected to hamper the global nuclear/ radiopharmaceuticals market growth. Also, logistical difficulties, supply shortage and lack of qualified professionals will affect the global nuclear medicine/ radiopharmaceuticals market growth. Market Segmentation Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into type such as Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals, Tc-99m, Tl-201, Ga-67, and Others), PET Radiopharmaceuticals (F-18, Rubidium-82, and Others), by procedure such as Brachytherapy Isotopes, Alpha Emitters, Beta Emitters, Therapeutic Procedures, PET Radiopharmaceuticals, and SPECT Radiopharmaceuticals. Further, Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into application such as Cardiology, Oncology, Neurology, Thyroid, and Others. Ask for Customization @https://qualiketresearch.com/request-sample/Nuclear- MedicineRadiopharmaceuticals-Market/ask-for-customization Also, Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Market Key Players Various key players are discussed in this report such as Iba Molecular, Advanced Accelerator Applications S.A., Nordion, Inc, Eczacibasi-Monrol Nuclear Products, Bracco Imaging S.P.A, Bayer AG, Lantheus Medical Imaging, Inc., GE Healthcare, Mallinckrodt PLC, and Cardinal Health, Inc. Market Taxonomy By Type •Diagnostic Nuclear Medicine oSPECT Radiopharmaceuticals

  3. oTc-99m oTl-201 oGa-67 oOthers •PET Radiopharmaceuticals oF-18 oRubidium-82 oOthers By Procedure •Brachytherapy Isotopes •Alpha Emitters •Beta Emitters •Therapeutic Procedures •PET Radiopharmaceuticals •SPECT Radiopharmaceuticals Browse Full Research Report @ https://qualiketresearch.com/reports-details/Nuclear- MedicineRadiopharmaceuticals-Market By Application •Cardiology •Oncology •Neurology •Thyroid •Others

  4. By Region •North America •Latin America •Asia Pacific •Europe •Middle East & Africa Get in touch QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. Contact Person: Vishal Thakur Research Support Specialist QualiKet Research 6060 N Central Expy #500, TX 75204, U.S.A sales@qualiketresearch.com Website: https://qualiketresearch.com

More Related